Yes, this is because prolonged drops in testosterone also affect negatively sex-related emotional responses. As the libido decreases, it becomes more difficult to achieve and maintain effective penile erections that allow for a full sex life.
Female hypogonadism refers to a hormonal disorder of the ovaries to produce estrogens and progestogens, the quintessential female sex hormones.
In addition to altering menstrual cycles and decreasing the ability to ovulate (and therefore have children), hypogonadism also has effects on other systems. It promotes the early onset of menopause.
It is diagnosed with physical examinations and laboratory tests, to measure the blood levels of these ovarian hormones and those of the Hypothalamic–pituitary axis.
Treatment consists of hormone replacement therapy, similar to men's but with estrogens and progestogens. It is generally performed with doses that vary according to the passage of days to stimulate or simulate the hormonal changes typical of the menstrual cycle.
Much less frequent than hypogonadism, hypergonadism refers to the endocrine pathology in which the body of a man or woman secretes high amounts of sexual hormones per day, testosterone in men and estrogens and progestogens in women.
The most obvious clinical manifestations are alterations in body development, changes in behaviour and sleep patterns. There may also be problems with having children.
Male hypergonadism is associated with prostate cancer. <span">Its treatment involves the administration of drugs that decrease the body's response to testosterone. That is, they make some tissues (such as the testicles) less sensitive to testosterone.